ARTICLE | Clinical News
Neupro regulatory update
October 4, 2004 7:00 AM UTC
Schwarz submitted an NDA to FDA for Neupro, a dopamine D2 receptor agonist patch, to treat Parkinson's disease (PD). Separately, Schwarz submitted an MAA to EMEA in the same indication. ...